hematuria workup: ??too much radiation
A theoretical analysis suggested that our current guidelines (via Am Urol Assn) to working up hematuria, vs guidelines in several other countries, may well lead to increased radiation-induced cancer (see hematuria avoid CT jamaintmed2019 in dropbox, or doi:10.1001/jamainternmed.2019.2280)
Details:
-- current guidelines for working up hematuria:
-- American Urological Association (AUA): if
>35 yo, cystoscopy plus CT urography
-- Dutch: if >50 yo, cystoscopy plus
ultrasonography
-- Canadian Urological Association (CUA): if
>40 yo, cystoscopy plus ultrasonography
-- Kaiser Permanente (KP): if patients had
gross hematuria, cystoscopy along with CT urography; smokers, males, or anyone
>50yo had cystoscopy plus ultrasonography; non-smoking females <50yo had
no workup
-- Hematuria Risk Index (HRI): risk scores were
calculated, and no workup if low-risk, cystoscopy plus ultrasound if moderate
risk, cystoscopy and CT if high risk (see more on this below)
-- hypothetical cohort of 100,000 patients with hematuria aged 35
or older. they modeled the data from 2 large prospective hematuria cohorts on
patients' ages, sex, smoking status and history of gross hematuria, and the
statistical likelihood of different types of urinary tract. they included patients
with both microhematuria and gross hematuria in their simulated grouping (based
on the relative frequency of each in the population) vs just asymptomatic
microhematuria (much more common but lower likelihood of cancer)
-- main outcome: urinary tract detection rates, radiation-induced
secondary cancers from CT scans, procedural complications, false positive rates
per 100,000 patients, and incremental cost per additional urinary tract cancer
detected
Results:
-- 3514 patients in the simulated cohort had urinary tract
cancers, estimated prevalence 3.5%: 2978 bladder cancer, 443 renal cell cancers
(RCC), 93 upper tract urothelial cancers (UTUC)
-- AUA:
-- cancers: 3432 detected/82 missed, 2.3% (ie 97.7%
picked up); 2918 bladder cancers detected/60 missed, 425 RCC detected/19
missed, 89 UTUC detected/5 missed
-- radiation-induced cancers: 575
-- clinical outcomes: UTI from cystoscopy 1902,
dysuria 11,003, false positive cases 22,189
-- CT associated events: CT allergy 618,
contrast nephropathy 4114
-- total cost $939 per person, false positive
cost from results of initial workup $94 (not including costs of downstream
testing)
--Dutch:
-- cancers: 3263 detected/251 missed,
7.1% (ie 92.9% picked up); 2838 bladder cancers detected/141
missed, 360 RCC detected/82 missed, 65 UTUC detected/28 missed
-- radiation-induced cancers: none
-- clinical outcomes: UTI from cystoscopy 1179,
dysuria 6820, false positive cases 6452
-- CT associated events: none
-- total cost $442 per person, false positive
cost from results of initial workup $2426
-- CUA:
-- cancers: 3343 detected/172 missed,
4.9% (ie 95.1% picked up); 2906 bladder cancers detected/72
missed, 371 RCC detected/72 missed, 65 UTUC detected/28 missed
-- radiation-induced cancers: none
-- clinical outcomes: UTI from cystoscopy 1230,
dysuria 7114, false positive cases 6740
-- CT associated events: none
-- total cost $462 per person, false positive
cost from results of initial workup $25 per person
-- KP:
-- cancers: 3385 detected/130 missed,
3.7% (ie 96.3% picked up); 2907 bladder cancers detected/71
missed, 397 RCC detected/46 missed, 80 UTUC detected/13 missed
-- radiation-induced cancers: 108
-- clinical outcomes: UTI from cystoscopy 1260,
dysuria 7289, false positive cases 9099
-- CT associated events: CT allergy 135,
contrast nephropathy 898
-- total cost $519 per person, false positive
cost from results of initial workup $36 per person
-- HRI:
-- cancers: 3399 detected/116 missed,
3.3% (ie 96.7% picked up); 2907 bladder cancers detected/71
missed, 404 RCC detected/39 missed, 87 UTUC detected/6 missed
-- radiation-induced cancers: 136
-- clinical outcomes: UTI from cystoscopy 1260,
dysuria 7289, false positive cases 13,811
-- CT associated events: CT allergy 151,
contrast nephropathy 1009
-- total cost $598, false positive cost from
results of initial workup $59
-- cost per additional cancer case detected, as compared to the
least expensive Dutch guidelines as the reference (costs in 2017 US$) [these
are the increased costs to detect one case over what would have been detected
following the Dutch guidelines]
-- CUA: $23,864
-- KP: $137,063
-- HRI: $559,378
-- AUA: $1,034,374
Commentary:
--so, this study found that through mathematical modeling, the
least invasive strategy (via the Dutch recommendations) does pretty well
(picking up 93% of cancers) with zero radiation-induced cancer [though, it
should be noted, this “zero” rate is only for the initial screen, and any
concerning finding on ultrasound is likely followed up by radiologic imaging]
--raising the age from 40 to 50yo per the CUA over the Dutch
guidelines had an incremental cost of $23,864 per additional cancer detected
--the AUA guidelines had the highest detection rate for cancers,
but many more adverse events related to CT scanning including induced cancers,
and by far the highest cost per additional cancer detected. And lots more false
positive results
-- And the AUA, unlike some other guidelines,
suggest workup of a single urinalysis with >3 RBCs/hpf (vs repeatedly
positive tests) [per the 2012 AUA guidelines: asymptomatice microhematuria
"is defined as 3 or greater RBCs/hpf on a properly collected urinary
specimen in the absence of an obvious benign cause", though they also
note that there is variability in microhematuria from one time to the next
(see hematuria guidelines AUA 2012.pdf in dropbox, or doi.org/10.1016/j.juro.2012.09.078)
--the HRI approach evolved from a prospective cohort study of
2630 patients with microscopic hematuria seen by urologists in
Kaiser-Permanente over a 2-year period, finding that 55 (2.1%) had a
neoplasm and 50 (1.9%) had pathologically-confirmed cancer, more so in
those with recent diagnosis of gross hematuria, in men, and those >50yo,
though smoking history and >25 RBC per high power field were not
statistically significant (see hematuria cancer HRI in dropbox,
or doi.org/10.1016/j.mayocp.2012.10.004)
--the current authors comment that the guidelines often conflate
microhematuria and gross hematuria as if they should have the same approach,
though gross hematuria is more predictive of cancer
--the major concern here is that:
--the use of CT scans is increasing dramatically
(6-fold in the past 3 decades)
--analyses have found that about 1/2 of the ordered
CT scans may be unnecessary
--about 2 million Americans annually are referred to
urologists for hematuria (and this does not include the number of patients
having CT scans for hematuria but ordered by non-urologists,
like us in primary care)
--CT scans pick up lots of incidental findings,
which often beget more CT scans (and more radiation), plus also patient
anxiety, subjection to more tests, possibly invasive procedures, possible
adverse effects of these tests/procedures, and often unclear benefit of these
incidental detections and array of interventions
--i have found several patients with "incidental" renal cell
cancers, a not so uncommon issue since the increased use of abdominal imaging.
are these real cancers that behave the same way as ones picked up through symptoms??
are they more similar to prostate cancers, where some are really bad actors but
others are indolent and people die late in life from other causes? do these
patients need pretty urgent surgery, as my patients had? are these simply
overdiagnoses (are some/many of the cancers picked up through a few RBCs in the
urine really just incidental findings unrelated to the hematuria?)? are we
really saving lots of lives by cutting the cancers out?????
--the Choosing Wisely campaign to decrease
unnecessary medical tests, treatments and procedures has disproportionately
targeted medical imaging as unnecessary
--abdominal and pelvic CTs confer the highest
radiation dose of commonly performed CT scans
--and, there is remarkably/shockingly high variability
of the actual dose of radiation given with an abdominal/pelvic CT: from 6.4 to
90 mSv per exam [in
the current study they comment that the actual range
in the community may be from 3.5-144 mSv, which per the AUA guidelines would
increase the number of radiation-induced cancers from 575 to 782/100,000
--and, significantly, radiation-induced
cancer has a case fatality rate of >50%
--one side issue of interest (at least to me) in conceptualizing
cancer is that there is a complex interplay between the genetic mutations and
the environment:
--as several blogs have noted, there is typically
not a genetic imperative to developing cancer; genes are not determinant even
in mututions such as BRCA
--analysis of the 23andMe genetic
evaluations have found remarkably poor sensitivity and specificity for clinical
disease (see http://gmodestmedblogs.blogspot.com/2017/04/23andme-genetic-analysis-approved-for.html
)
--we all develop potentially serious
mutations with aging, more so with exposure to such things as radiation or
smoking
--several studies have found a lower
risk of cancer with a healthier lifestyle. one factor that may well be involved
is inflammation (eg see http://gmodestmedblogs.blogspot.com/2016/08/normal-bmiexercise-lower-cancer-risk-2.html for
decreased cancer with exercise; http://gmodestmedblogs.blogspot.com/2015/11/breast-cancer-risk-and-mediterranean.html for
decreased breast cancer with Mediterranean diet )
--a healthy lifestyle
does decrease inflammation: see http://gmodestmedblogs.blogspot.com/2019/01/non-animal-protein-diet-dec-inflammation.html , or http://gmodestmedblogs.blogspot.com/2018/12/mediterranean-diet-dec-cad-and.html
--studies have shown
that inflammation increases the growth of tumor cells and the risk of
metastatic disease, eg see cancer and inflammation cell2010 in
dropbox or doi 10.1016/j.cell.2010.01.025 or https://www.cell.com/action/showPdf?pii=S0092-8674%2810%2900060-7 )
--aspirin has been shown to
decrease the risk of metastatic cancer and cancer deaths, moreso in
smokers: see aspirin cancer mets lancet 2012 in dropbox, or Rothwell
PM. lancet. 2012; 379: 1591
-- One basic concern with mathematical modeling for radiation
exposure is the rather limited database to derive the estimates. The most
studied involve the effects of atomic bomb blasts in Hiroshima and Nagasaki, looking
at distance from the blast (a surrogate for differences in radiation exposure)
and cancer incidence. As a model, this is very approximate: the study involves
a single ethnic group, different baseline environmental exposures from other
groups, and the application of results from a “normal” population (for
example, those with hematuria may well have underlying noncancerous pathology,
and the addition of ionizing radiation to that pathology may increase the risk
of cancer more than in a normal population). eg see https://www.pnas.org/content/pnas/100/24/13761.full.pdf ,
or radiation and cancer risk lancet2015 in dropbox, or Kamiya K. Lancet.
2015; 386:469
--note that the above false positive costs include the monetary
costs only, not include the cost of downstream testing, including workup
of incidental findings (found in >30% of CTs), anxiety, patient/family
burden, physical risks, patient costs (out-of pocket, esp)
so, seems to me that the Am Urol Assn guidelines are a bit on the
aggressive side. A few % higher pickup of cancers, but lots more radiation and
likely radiation-induced cancers. And lots more false positive results (likely
leading to even more radiation exposure as a followup). probably makes
sense to:
--check on the local CT scanner used (eg in the hospital) and see
what the actual radiation exposure is (by reference, a chest CT
yields 8 mSv), given the very huge apparent variation in the community.
And we should advocate strongly for newer CT scanners if the radiation exposure
is high
--the patients should understand that radiation can be associated
with creating cancer, and that there is this potential downside with pretty
much all xrays and their use should be minimized. my experience is that xrays
have been so normalized in our culture that patients do not understand that
there really are any risks. and when i mention the risks, the patients are
often surprised and less interested in getting xrays (this has been particularly
successful in discussing risks of biennial vs annual mammograms)
--the Canadian guidelines do seem to be a reasonable approach,
with its lower age group inclusion (40yo, vs 50yo in the Dutch guidelines),
especially since the effects of missing a cancer in the 40-50yo probably has a
higher overall social value than in an 80-90yo, esp in terms of potential years
of life lost
and family/community effects.
For some prior blogs on radiation-induced cancer:
http://gmodestmedblogs.blogspot.com/2018/06/low-dose-radiation-and-subsequent.html looks
at adults with congenital heart disease, finding a significant increase in
cancer years after exposure to ionizing radiation, with higher rates associated
with more exposure
http://gmodestmedblogs.blogspot.com/2013/07/ct-scanning-in-kids-and-radiation.html for
projected effects of CT scanning in kids on cancer risk
geoff
If you would like to be on the
regular email list for upcoming blogs, please contact me at gmodest@uphams.org
to get access to all of the
blogs:
to see them in reverse chronological order
2. click on 3 parallel lines
top left, if you want to see blogs by category, then click on
"labels" and choose a category
3. or you can just click on
the magnifying glass on top right, then type in a name in the search box
and get all the blogs with that name in them
please feel free to circulate
this to others. also, if you send me their emails, i can add them to the list
Comments
Post a Comment
if you would like to receive the near-daily emails regularly, please email me at gmodest@uphams.org